Evidence map›Paper›PMID 25763640›Full record

ArticleEndocrinology2015

Inhibition of Small Maf Function in Pancreatic β-Cells Improves Glucose Tolerance Through the Enhancement of Insulin Gene Transcription and Insulin Secretion.

Hiroshi Nomoto, Takuma Kondo, Hideaki Miyoshi, Akinobu Nakamura, Yoko Hida, Ken-ichiro Yamashita, Arun J Sharma, Tatsuya Atsumi

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Metabolic memory: mechanisms and diseases.Signal transduction and targeted therapy · 2024
    Review
  3. Article
  4. Article
  5. Global polysome analysis of normal and injured podocytes.American journal of physiology. Renal physiology · 2019
    Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Hiroshi NomotoDivision of Rheumatology, Endocrinology and Nephrology (H.N., T.K., H.M., A.N., Y.H., T.A.), and Department of Transplant Surgery (K.Y.), Hokkaido University Graduate School of Medicine, Sapporo, Japan 060-8638; Section of Islet Transplantation and Cell Biology (A.J.S.), Joslin Diabetes Center, Boston, Massachusetts 02215; and MedImmune LLC (A.J.S.), Gaithersburg, Maryland 20878.
Takuma KondoDivision of Rheumatology, Endocrinology and Nephrology (H.N., T.K., H.M., A.N., Y.H., T.A.), and Department of Transplant Surgery (K.Y.), Hokkaido University Graduate School of Medicine, Sapporo, Japan 060-8638; Section of Islet Transplantation and Cell Biology (A.J.S.), Joslin Diabetes Center, Boston, Massachusetts 02215; and MedImmune LLC (A.J.S.), Gaithersburg, Maryland 20878.
Hideaki MiyoshiDivision of Rheumatology, Endocrinology and Nephrology (H.N., T.K., H.M., A.N., Y.H., T.A.), and Department of Transplant Surgery (K.Y.), Hokkaido University Graduate School of Medicine, Sapporo, Japan 060-8638; Section of Islet Transplantation and Cell Biology (A.J.S.), Joslin Diabetes Center, Boston, Massachusetts 02215; and MedImmune LLC (A.J.S.), Gaithersburg, Maryland 20878.
Akinobu NakamuraDivision of Rheumatology, Endocrinology and Nephrology (H.N., T.K., H.M., A.N., Y.H., T.A.), and Department of Transplant Surgery (K.Y.), Hokkaido University Graduate School of Medicine, Sapporo, Japan 060-8638; Section of Islet Transplantation and Cell Biology (A.J.S.), Joslin Diabetes Center, Boston, Massachusetts 02215; and MedImmune LLC (A.J.S.), Gaithersburg, Maryland 20878.
Yoko HidaDivision of Rheumatology, Endocrinology and Nephrology (H.N., T.K., H.M., A.N., Y.H., T.A.), and Department of Transplant Surgery (K.Y.), Hokkaido University Graduate School of Medicine, Sapporo, Japan 060-8638; Section of Islet Transplantation and Cell Biology (A.J.S.), Joslin Diabetes Center, Boston, Massachusetts 02215; and MedImmune LLC (A.J.S.), Gaithersburg, Maryland 20878.
Ken-ichiro YamashitaDivision of Rheumatology, Endocrinology and Nephrology (H.N., T.K., H.M., A.N., Y.H., T.A.), and Department of Transplant Surgery (K.Y.), Hokkaido University Graduate School of Medicine, Sapporo, Japan 060-8638; Section of Islet Transplantation and Cell Biology (A.J.S.), Joslin Diabetes Center, Boston, Massachusetts 02215; and MedImmune LLC (A.J.S.), Gaithersburg, Maryland 20878.
Arun J SharmaDivision of Rheumatology, Endocrinology and Nephrology (H.N., T.K., H.M., A.N., Y.H., T.A.), and Department of Transplant Surgery (K.Y.), Hokkaido University Graduate School of Medicine, Sapporo, Japan 060-8638; Section of Islet Transplantation and Cell Biology (A.J.S.), Joslin Diabetes Center, Boston, Massachusetts 02215; and MedImmune LLC (A.J.S.), Gaithersburg, Maryland 20878.
Tatsuya AtsumiDivision of Rheumatology, Endocrinology and Nephrology (H.N., T.K., H.M., A.N., Y.H., T.A.), and Department of Transplant Surgery (K.Y.), Hokkaido University Graduate School of Medicine, Sapporo, Japan 060-8638; Section of Islet Transplantation and Cell Biology (A.J.S.), Joslin Diabetes Center, Boston, Massachusetts 02215; and MedImmune LLC (A.J.S.), Gaithersburg, Maryland 20878.
Hokkaido University · JPJoslin Diabetes Center · US

Funding

RIPE3b1, An Important Insulin Gene Transcription FactorR01DK060127 · NIDDK · JOSLIN DIABETES CENTER · PI SHARMA, ARUN J · 2003 to 2010
$2.5M
NIDDK NIH HHS R01 DK060127NIDDK NIH HHS R01 DK60127
6 · The paper itself

Abstract

The large-Maf transcription factor v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (MafA) has been found to be crucial for insulin transcription and synthesis and for pancreatic β-cell function and maturation. However, insights about the effects of small Maf factors on β-cells are limited. Our goal was to elucidate the function of small-Maf factors on β-cells using an animal model of endogenous small-Maf dysfunction. Transgenic (Tg) mice with β-cell-specific expression of dominant-negative MafK (DN-MafK) experiments, which can suppress the function of all endogenous small-Mafs, were fed a high-fat diet, and their in vivo phenotypes were evaluated. Phenotypic analysis, glucose tolerance tests, morphologic examination of β-cells, and islet experiments were performed. DN-MafK-expressed MIN6 cells were also used for in vitro analysis. The results showed that DN-MafK expression inhibited endogenous small-Maf binding to insulin promoter while increasing MafA binding. DN-MafK Tg mice under high-fat diet conditions showed improved glucose metabolism compared with control mice via incremental insulin secretion, without causing changes in insulin sensitivity or MafA expression. Moreover, up-regulation of insulin and glucokinase gene expression was observed both in vivo and in vitro under DN-MafK expression. We concluded that endogenous small-Maf factors negatively regulates β-cell function by competing for MafA binding, and thus, the inhibition of small-Maf activity can improve β-cell function.

Indexed as

AnimalsBiomarkersDiet, High-FatGlucoseGlucose Tolerance TestImmunohistochemistryInsulinInsulin-Secreting CellsIslets of LangerhansMaleMiceMice, Inbred C57BLMice, TransgenicPhenotypePromoter Regions, GeneticProtein BindingBiomarkersGlucoseInsulinMaf protein, mouseProto-Oncogene Proteins c-maf

Identifiers

PMID25763640
PMCPMC4588816
OpenAlexW2131824619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.